PROTHENA CORPORATION PUBLIC LIMITED COMPANY Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2021-11-04: Form 10-Q; Exhibit 10.5; Description U.S. License Agreement, dated as of July 30, 2021, as amended on August 12, 2021 and September 8, 2021, by and between Prothena Biosciences Limited and Celgene Switzerland LLC.
- 2021-11-04: Form 10-Q; Exhibit 10.4; Description Share Purchase Agreement, dated as of July 8, 2021, by and among Novo Nordisk A/S, Novo Nordisk Region Europe A/S, Prothena Corporation plc, and Prothena Biosciences Limited.
- 2021-11-04: Form 10-Q; Exhibit 10.3; Description Amendment No. 2 to License, Development, and Commercialization Agreement, entered into on December 11, 2013, among Prothena Biosciences Limited, Prothena Biosciences Inc, F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc..
- 2021-11-04: Form 10-Q; Exhibit 10.2; Description Amended and Restated Consulting Agreement, dated July 15, 2020, between Prothena Biosciences Inc and Dennis J. Selkoe.
| Filed | Form | Exhibit | Description |
|---|
| 2021-11-04 | 10-Q | 10.5 | U.S. License Agreement, dated as of July 30, 2021, as amended on August 12, 2021 and September 8, 2021, by and between Prothena Biosciences Limited and Celgene Switzerland LLC |
|---|
| 2021-11-04 | 10-Q | 10.4 | Share Purchase Agreement, dated as of July 8, 2021, by and among Novo Nordisk A/S, Novo Nordisk Region Europe A/S, Prothena Corporation plc, and Prothena Biosciences Limited |
|---|
| 2021-11-04 | 10-Q | 10.3 | Amendment No. 2 to License, Development, and Commercialization Agreement, entered into on December 11, 2013, among Prothena Biosciences Limited, Prothena Biosciences Inc, F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc. |
|---|
| 2021-11-04 | 10-Q | 10.2 | Amended and Restated Consulting Agreement, dated July 15, 2020, between Prothena Biosciences Inc and Dennis J. Selkoe |
|---|
| 2021-11-04 | 10-Q | 10.1 | Tenth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan |
|---|
| 2021-08-05 | 10-Q | 10.3 | Ninth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan |
|---|
| 2021-08-05 | 10-Q | 10.2 | Eighth Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan |
|---|
| 2021-05-21 | 8-K | 10.1 | Second Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan |
|---|
| 2021-05-11 | 10-Q | 10.2 | Seventh Amendment to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan |
|---|
| 2021-05-11 | 10-Q | 10.1 | Offer Letter, dated March 18, 2021, between Prothena Biosciences Inc and Hideki Garren |
|---|
| 2021-02-26 | 10-K | 10.35 | Consulting Agreement, dated July 15, 2020, between Prothena Biosciences Inc and Dennis J. Selkoe |
|---|
| 2021-02-26 | 10-K | 10.17 | First through Sixth Amendments to the Prothena Corporation plc 2020 Employment Inducement Incentive Plan |
|---|